Media Coverage
Antoni Ribas receives 2026 ESMO lifetime achievement award
Icon
OncoDaily
There won’t be a single cancer vaccine, but rather a different one for each patient and tumor
Icon
El País
Cancer treatment could face landmark moment with promising vaccine
Icon
Washington Post
New hope for patients battling melanoma: A vaccine is showing positive results in a first-ever late stage trial
Icon
CBS Los Angeles
How decades of NCI support led to groundbreaking discoveries: the story of immune checkpoint inhibitors
Icon
OncoDaily
Pembrolizumab monotherapy shows promise in desmoplastic melanoma
Icon
Oncology Times
Rare melanoma trial serves as model for advancing cancer immunotherapy
Icon
Targeted Oncology
Cancer in 2026: How immunotherapy is reshaping the odds
Icon
Cancer Research Institute